PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $298,977 | -23.4% | 9,745 | 0.0% | 0.19% | -14.6% |
| Q2 2023 | $390,482 | -18.3% | 9,745 | -16.8% | 0.23% | -11.4% |
| Q1 2023 | $477,885 | +5.7% | 11,710 | 0.0% | 0.26% | +22.6% |
| Q4 2022 | $452,123 | -26.8% | 11,710 | +0.9% | 0.21% | -35.2% |
| Q3 2022 | $618,000 | -8.7% | 11,611 | 0.0% | 0.32% | -2.7% |
| Q2 2022 | $677,000 | -27.6% | 11,611 | -5.2% | 0.33% | -13.8% |
| Q1 2022 | $935,000 | -0.6% | 12,251 | -21.6% | 0.38% | +1.3% |
| Q4 2021 | $941,000 | +8.0% | 15,636 | +0.5% | 0.38% | -3.3% |
| Q3 2021 | $871,000 | -7.7% | 15,559 | 0.0% | 0.39% | -8.2% |
| Q2 2021 | $944,000 | -13.5% | 15,559 | 0.0% | 0.43% | +6.5% |
| Q1 2021 | $1,091,000 | +10.4% | 15,559 | -5.8% | 0.40% | +0.5% |
| Q4 2020 | $988,000 | -2.9% | 16,509 | -2.4% | 0.40% | -10.8% |
| Q3 2020 | $1,017,000 | +12.1% | 16,919 | -2.1% | 0.45% | +3.5% |
| Q2 2020 | $907,000 | +56.4% | 17,289 | 0.0% | 0.43% | +45.6% |
| Q1 2020 | $580,000 | +9.2% | 17,289 | +47.5% | 0.30% | +53.4% |
| Q4 2019 | $531,000 | +19.1% | 11,719 | 0.0% | 0.19% | +37.9% |
| Q3 2019 | $446,000 | -12.5% | 11,719 | 0.0% | 0.14% | -4.1% |
| Q2 2019 | $510,000 | – | 11,719 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |